Reply to Ghosh et al(1). Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder

BIPOLAR DISORDERS（2022）

引用 1|浏览9

暂无评分

摘要

We reviewed Ghosh et al. letter based on our active-controlled, double-blind, and randomized trial that demonstrated the therapeutic benefit of Endoxifen in patients with bipolar I disorder.

查看译文

关键词

bipolar I disorder, endoxifen, valproate, YMRS Score

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要